RetinalGeniX Technologies to Provide Diagnostic Testing Services for MEDsan
RetinalGeniX Technologies Inc., has contracted with MEDsan, Inc. to provide diagnostic testing...
Read MorePosted by Chris Wolski | Dec 26, 2023 | Company News |
RetinalGeniX Technologies Inc., has contracted with MEDsan, Inc. to provide diagnostic testing...
Read MorePosted by Andy Lundin | Dec 20, 2023 | Diagnostic Technologies |
The AMP published a report that explores specific considerations for a slice testing strategy for diagnostics.
Read MorePosted by Chris Wolski | Dec 18, 2023 | Molecular Diagnostics |
Next-generation sequencing is at the forefront of the precision medicine revolution, offering the promise to empower tailored patient care.
Read MorePosted by Andy Lundin | Dec 15, 2023 | Molecular Diagnostics |
New findings could help personalize mental health care and potentially identify new targets for future drugs.
Read MorePosted by Andy Lundin | Dec 12, 2023 | Lung Cancer |
Liquid biopsies could predict which lung cancer patients are responding to immunotherapies or may develop immune-related side effects.
Read More